AbClon Balance Sheet Health
Financial Health criteria checks 5/6
AbClon has a total shareholder equity of ₩27.2B and total debt of ₩12.5B, which brings its debt-to-equity ratio to 46%. Its total assets and total liabilities are ₩45.4B and ₩18.2B respectively.
Key information
46.0%
Debt to equity ratio
₩12.53b
Debt
Interest coverage ratio | n/a |
Cash | ₩17.50b |
Equity | ₩27.23b |
Total liabilities | ₩18.19b |
Total assets | ₩45.42b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A174900's short term assets (₩19.3B) exceed its short term liabilities (₩17.6B).
Long Term Liabilities: A174900's short term assets (₩19.3B) exceed its long term liabilities (₩589.9M).
Debt to Equity History and Analysis
Debt Level: A174900 has more cash than its total debt.
Reducing Debt: A174900's debt to equity ratio has increased from 10.7% to 46% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A174900 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A174900 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 18.6% each year.